Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SP5M001 vs Synovian in Knee Osteoarthritis
NCT06307847Phase 3Completed
- Sponsor
- Shinpoong Pharma
- Start
- Apr 2021
- Primary completion
- Oct 2022
- Modality
- Polymer-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 3 trial of Hyalflex in osteoarthritis (OA), sponsored by Shinpoong Pharma. Started Apr 2021; status: completed.
02
Drugs
Hyalflex
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT06307847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06307847.